XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Condensed Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Revenue $ 57,445 $ 51,469 $ 112,208 $ 101,072
Cost of products sold 55,599 49,806 108,594 97,795
Gross margin 1,846 1,663 3,614 3,277 Close
Operating expenses:         Close
Distribution, selling, general and administrative expenses 1,283 1,191 2,480 2,388 Close
Restructuring and employee severance 28 17 53 46 Close
Amortization and other acquisition-related costs 63 71 127 142 Close
Impairments and (gain)/loss on disposal of assets, net 1 710 538 863 Close
Litigation (recoveries)/charges, net (11) (207) (52) (180) CloseClose
Total Operating Expenses 1364.0 1782.0 3146.0 3259.0 0 Close
Operating earnings/(loss) 482 (119) 468 18 Close
Other (income)/expense, net (16) (7) (18) (5) CloseClose
Total Other Income Expenses -8.0 18.0 4.0 45.0 0.0 Close
Interest expense, net 8 25 22 50 CloseClose
Earnings/(loss) before income taxes 490 (137) 464 (27) Close
Provision for/(benefit from) income taxes 136 (7) 104 (8) Close
Net earnings/(loss) 354 (130) 360 (19) Close
Less: Net earnings attributable to noncontrolling interests (1) 0 (2) (1)
Net earnings/(loss) attributable to Cardinal Health, Inc. $ 353 $ (130) $ 358 $ (20)
Earnings/(Loss) per common share attributable to Cardinal Health, Inc.:        
Basic (in shares) $ 1.44 $ (0.50) $ 1.45 $ (0.08)
Diluted (in shares) $ 1.43 $ (0.50) $ 1.44 $ (0.08)
Weighted-average number of common shares outstanding:        
Basic (in shares) 245 261 247 266
Diluted (in shares) 246 261 248 266
Cash dividends declared per common share $ 0.5006 $ 0.4957 $ 1.0012 $ 0.9914